43602-426-30 |
43602-426 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.175 mg/1 |
30 TABLET in 1 BOTTLE (43602-426-30) |
43602-426-90 |
43602-426 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.175 mg/1 |
90 TABLET in 1 PACKAGE (43602-426-90) |
43602-427-10 |
43602-427 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.2 mg/1 |
1000 TABLET in 1 BOTTLE (43602-427-10) |
43602-427-30 |
43602-427 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.2 mg/1 |
30 TABLET in 1 BOTTLE (43602-427-30) |
43602-427-90 |
43602-427 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.2 mg/1 |
90 TABLET in 1 BOTTLE (43602-427-90) |
43602-428-10 |
43602-428 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
1000 TABLET in 1 BOTTLE (43602-428-10) |
43602-428-30 |
43602-428 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
30 TABLET in 1 BOTTLE (43602-428-30) |
43602-428-90 |
43602-428 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
90 TABLET in 1 BOTTLE (43602-428-90) |